GreenLight Biosciences Holdings

NasdaqGM:GRNA Stock Report

Market Cap: US$45.4m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

GreenLight Biosciences Holdings Management

Management criteria checks 3/4

GreenLight Biosciences Holdings' CEO is Andrey Zarur, appointed in Aug 2008, they has a tenure of 14.92 years. Their total yearly compensation is $576.56K , comprised of 99.7% salary and 0.3% bonuses, including company stock and options. They directly owns 0.59% of the company’s shares, worth $268.37K. The average tenure of the management team and the board of directors is 1.3 years and 4.4 years respectively.

Key information

Andrey Zarur

Chief executive officer

US$576.6k

Total compensation

CEO salary percentage99.7%
CEO tenure14.9yrs
CEO ownership0.6%
Management average tenure1.3yrs
Board average tenure4.4yrs

Recent management updates

Recent updates

GreenLight Biosciences cutting 25% of staff as part of realignment

Oct 12

GreenLight Biosciences launches $109M in financing

Aug 12

GreenLight Biosciences, Samsung Biologics complete commercial-scale engineering run for mRNA COVID-19 vaccine

Aug 01

GreenLight Biosciences: Synthesizing Cell-Free RNA

Apr 05

CEO Compensation Analysis

How has Andrey Zarur's remuneration changed compared to GreenLight Biosciences Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2023n/an/a

-US$157m

Dec 31 2022US$577kUS$575k

-US$167m

Sep 30 2022n/an/a

-US$163m

Jun 30 2022n/an/a

-US$154m

Mar 31 2022n/an/a

-US$129m

Dec 31 2021US$728kUS$500k

-US$112m

Sep 30 2021n/an/a

-US$86m

Jun 30 2021n/an/a

-US$89m

Mar 31 2021n/an/a

-US$75m

Dec 31 2020US$2mUS$450k

-US$53m

Compensation vs Market: Andrey's total compensation ($USD576.56K) is about average for companies of similar size in the US market ($USD749.31K).

Compensation vs Earnings: Andrey's compensation has been consistent with company performance over the past year.


CEO

Andrey Zarur (52 yo)

14.9yrs

Tenure

US$576,561

Compensation

Dr. Andrey Juan Zarur, Ph.D. Co-founded GreenLight Biosciences Holdings (aka GreenLight Biosciences, Inc) in 2008 and serves as its President and Chief Executive Officer since August 2008. Dr. Zarur serves...


Leadership Team

NamePositionTenureCompensationOwnership
Andrey Zarur
Co-Founder14.9yrsUS$576.56k0.59%
$ 268.4k
Susan Keefe
CFO & Interim Chief Accounting Officer4.2yrsUS$1.28m0%
$ 0
Carole Cobb
Chief Operating Officer7.5yrsUS$1.30m0%
$ 0
Marta Ortega-Valle
Co-founder and Chief Sustainability & Strategy Officerless than a yearno data0.020%
$ 8.9k
Drew Cunningham
Chief Technology Officer1.3yrsno datano data
Nina Thayer
General Counselless than a yearno datano data
Thomas Crampton
Senior VP & Head of Corporate Affairs2.5yrsno datano data
David Kennedy
Advisorno datano data0%
$ 0
Mark Singleton
Chief Commercial Officer & General Manager of Plant Health2.4yrsno data0%
$ 0
Shelly Karuna
Chief Medical Officerless than a yearno datano data
Kimberly Warren
Chief Business Officerless than a yearno datano data
Nicholas Skizim
Rollover Investorless than a yearno data0.018%
$ 8.1k

1.3yrs

Average Tenure

52yo

Average Age

Experienced Management: GRNA's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Andrey Zarur
Co-Founder14.9yrsUS$576.56k0.59%
$ 268.4k
Eric O'Brien
Independent Director4.1yrsUS$293.23k0%
$ 0
Charles Leland Cooney
Independent Chairman of the Board12.6yrsUS$429.53k0.20%
$ 91.5k
Ganesh Kishore
Independent Director8.5yrsUS$293.23k0%
$ 0
Theodore Ashburn
Advisorno datano datano data
Colin Steen
Board Observer4.2yrsno datano data
Martha Schlicher
Independent Director5.4yrsUS$293.23k0%
$ 0
Christopher Abbott
Board Observer4.2yrsno datano data
Mark Cupta
Board Observer4.2yrsno datano data
Luc Debruyne
Advisorno datano datano data
Matthew Walker
Independent Director4.6yrsUS$293.23k0.042%
$ 19.1k
David Russell
Board Observer4.2yrsno datano data

4.4yrs

Average Tenure

57.5yo

Average Age

Experienced Board: GRNA's board of directors are considered experienced (4.4 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.